Stephen Mullennix

2019

In 2019, Stephen Mullennix earned a total compensation of $1.3M as Chief Operating Officer at UroGen Pharma Ltd., a 69% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$261,375
Option Awards$436,108
Salary$435,625
Stock Awards$212,500
Other$904
Total$1,346,512

Mullennix received $436.1K in option awards, accounting for 32% of the total pay in 2019.

Mullennix also received $261.4K in non-equity incentive plan, $435.6K in salary, $212.5K in stock awards and $904 in other compensation.

Rankings

In 2019, Stephen Mullennix's compensation ranked 7,862nd out of 13,971 executives tracked by ExecPay. In other words, Mullennix earned more than 43.7% of executives.

ClassificationRankingPercentile
All
7,862
out of 13,971
44th
Division
Manufacturing
3,094
out of 5,695
46th
Major group
Chemicals And Allied Products
1,166
out of 2,194
47th
Industry group
Drugs
996
out of 1,880
47th
Industry
Pharmaceutical Preparations
739
out of 1,392
47th

Pay ratio

Stephen Mullennix's Pay$1,346,512
Median Employee's Pay$223,867
Pay Ratio

6

to 1

In 2019, the annual total compensation of Stephen Mullennix was $1,346,512.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $223,867.

The ratio of Stephen Mullennix's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 29, 2020.

Mullennix's colleagues

We found four more compensation records of executives who worked with Stephen Mullennix at UroGen Pharma Ltd. in 2019.

2019

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

2019

Peter Pfreundschuh

UroGen Pharma Ltd.

Chief Financial Officer

2019

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

2019

Ron Bentsur

UroGen Pharma Ltd.

Chief Executive Officer

News

You may also like